Study on Preventing Diabetic Atherosclerosis with Antiplatelet Drugs
Author Information
Author(s): Yamasaki Yoshimitsu, Kim Young-Seol, Kawamori Ryuzo
Primary Institution: Osaka University Faculty of Medicine
Hypothesis
Can antiplatelet therapy effectively prevent atherosclerosis in diabetic patients?
Conclusion
The study aims to clarify the efficacy of aspirin and cilostazol in preventing diabetic atherosclerosis.
Supporting Evidence
- The study is the first to use an online system for data pooling in an international clinical trial.
- It aims to address the rising incidence of diabetic atherosclerosis in Eastern Asia.
- The study design includes a two-year follow-up to assess the effectiveness of the treatments.
Takeaway
This study is trying to find out if two types of medicine can help people with diabetes avoid heart problems.
Methodology
Patients with type 2 diabetes were randomly assigned to receive either aspirin or cilostazol for two years.
Potential Biases
Potential bias in patient selection and reporting of outcomes.
Limitations
The study may not fully represent all diabetic patients due to specific inclusion and exclusion criteria.
Participant Demographics
Patients aged 40 to 85 with type 2 diabetes and signs of arteriosclerosis.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website